お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
944113

ライフサイエンス分析ソフトウェアの世界市場 - 製品別・用途別・提供方式別・エンドユーザー別:機会分析と産業予測 (2020~2027年)

Life Science Analytics Software Market by Product, Application, Delivery Model, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 289 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
ライフサイエンス分析ソフトウェアの世界市場 - 製品別・用途別・提供方式別・エンドユーザー別:機会分析と産業予測 (2020~2027年)
出版日: 2020年04月01日
発行: Allied Market Research
ページ情報: 英文 289 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のライフサイエンス分析ソフトウェア市場は、2019年には53億5000万米ドル、2027年には160億4000万米ドルと、12.3%のCAGRで成長すると予測されています。市場成長の主な要因として、各種疾患の有病者の増加や、医療費削減・臨床転帰改善の圧力、ビッグデータの普及と活用などが挙げられます。

当レポートでは、世界のライフサイエンス分析ソフトウェアの市場について分析し、製品の概要や市場の基本構造・最新動向、主な市場促進・抑制要因、今後の市場機会、市場規模の実績値・予測値 (今後8年間分)、製品別・用途別・提供方式別・エンドユーザー別・地域別の詳細動向、主要企業のプロファイルなどについて調査しております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資財源
    • 主な成功戦略
  • ポーターのファイブフォース分析
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第4章 世界のライフサイエンス分析ソフトウェアの市場:製品別

  • 概要
    • 市場規模とその予測
  • 記述的分析
    • 主な市場動向、成長要因、機会
    • 市場規模と予測:地域別
    • 市場分析:国ごと
  • 予測的分析
  • 処方的分析 (規範的分析)

第5章 世界のライフサイエンス分析ソフトウェアの市場:用途別

  • 概要
    • 市場規模と予測
  • 研究開発 (R&D)
  • 販売/マーケティング・サポート
  • 企業コンプライアンス
  • サプライチェーン分析
  • ファーマコビジランス (医薬品安全監視)

第6章 世界のライフサイエンス分析ソフトウェアの市場:提供方式別

  • 概要
    • 市場規模と予測
  • オンプレミス
  • クラウド

第7章 世界のライフサイエンス分析ソフトウェアの市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 製薬・バイオテクノロジー企業
  • 医療機器企業
  • 研究センター
  • 第三者管理機関 (TPA)

第8章 ライフサイエンス分析ソフトウェアの市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 主な市場動向、成長要因、機会
    • 市場規模とその予測:製品別
    • 市場規模とその予測:用途別
    • 市場規模とその予測:提供方式別
    • 市場規模とその予測:エンドユーザー別
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第9章 企業プロファイル

  • ACCENTURE PLC
  • ARISGLOBAL LLC
  • CHEMICAL ABSTRACTS SERVICES (ACS)
  • CERTARA, L.P.
  • CLARIVATE ANALYTICS PLC
  • COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
  • DASSAULT SYSTEMES
  • DELOITTE
  • IQVIA HOLDINGS INC
  • MICROSOFT CORPORATION
  • ORACLE CORPORATION
  • TIBCO SOFTWARE INC
  • VEEVA SYSTEMS INC
図表

LIST OF TABLES

  • TABLE 01.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 02.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FORPRESCRIPTIVE ANALYTICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 06.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 07.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SALES AND MARKETING SUPPORT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR REGULATORY COMPLIANCE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACOVIGILANCE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027($MILLION)
  • TABLE 13.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR ON-PREMISE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR CLOUD, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 16.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH CENTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 21.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 22.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 23.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 24.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 25.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 26.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 27.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 28.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 29.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 30.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 33.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 34.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 35.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 36.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 37.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 38.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 39.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 40.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 41.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 42.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 43.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 44.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 45.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 46.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 47.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 48.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 49.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 50.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 51.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 52.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 53.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 54.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 55.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 56.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 57.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 58.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 59.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 60.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 61.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 62.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 63.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 64.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 65.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 66.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 67.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 68.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 69.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 70.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 71.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 72.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 73.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 74.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 75.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 76.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 77.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 78.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 79.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 80.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 81.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 82.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 83.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 84.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 85.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 86.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 87.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 88.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 89.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 90.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 91.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 92.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 93.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 94.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 95.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 96.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 97.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 98.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 99.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 100.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 101.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 102.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 103.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 104.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 105.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 106.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 107.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 108.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 109.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 110.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 111.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019-2027 ($MILLION)
  • TABLE 112.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 113.ACCENTURE: COMPANY SNAPSHOT
  • TABLE 114.: PRODUCT SEGMENTS
  • TABLE 115.ACCENTURE: PRODUCT PORTFOLIO
  • TABLE 116.ARISGLOBAL: COMPANY SNAPSHOT
  • TABLE 117.ARISGLOBAL: OPERATING SEGMENTS
  • TABLE 118.ARISGLOBAL: PRODUCT PORTFOLIO
  • TABLE 119.CAS/ACS: COMPANY SNAPSHOT
  • TABLE 120.CAS/ACS: OPERATING SEGMENTS
  • TABLE 121.CAS/ACS: PRODUCT PORTFOLIO
  • TABLE 122.CERTARA: COMPANY SNAPSHOT
  • TABLE 123.CERTARA: OPERATING SEGMENTS
  • TABLE 124.CERTARA: PRODUCT PORTFOLIO
  • TABLE 125.CLARIVATE: COMPANY SNAPSHOT
  • TABLE 126.CLARIVATE: OPERATING BUSINESS SEGMENTS
  • TABLE 127.CLARIVATE: PRODUCT PORTFOLIO
  • TABLE 128.COGNIZANT: COMPANY SNAPSHOT
  • TABLE 129.COGNIZANT: OPERATING BUSINESS SEGMENTS
  • TABLE 130.COGNIZANT: PRODUCT PORTFOLIO
  • TABLE 131.DASSAULT: COMPANY SNAPSHOT
  • TABLE 132.DASSAULT: OPERATING BUSINESS SEGMENTS
  • TABLE 133.DASSAULT: PRODUCT PORTFOLIO
  • TABLE 134.DELOITTE: COMPANY SNAPSHOT
  • TABLE 135.DELOITTE: OPERATING SEGMENTS
  • TABLE 136.DELOITTE: PRODUCT PORTFOLIO
  • TABLE 137.IQVIA: COMPANY SNAPSHOT
  • TABLE 138.IQVIA: OPERATING SEGMENTS
  • TABLE 139.IQVIA: PRODUCT PORTFOLIO
  • TABLE 140.MICROSOFT: COMPANY SNAPSHOT
  • TABLE 141.MICROSOFT: OPERATING SEGMENTS
  • TABLE 142.MICROSOFT: PRODUCT PORTFOLIO
  • TABLE 143.ORACLE: COMPANY SNAPSHOT
  • TABLE 144.ORACLE: OPERATING SEGMENTS
  • TABLE 145.ORACLE: PRODUCT PORTFOLIO
  • TABLE 146.TIBCO: COMPANY SNAPSHOT
  • TABLE 147.TIBCO: OPERATING SEGMENTS
  • TABLE 148.TIBCO: PRODUCT PORTFOLIO
  • TABLE 149.VEEVA: COMPANY SNAPSHOT
  • TABLE 150.VEEVA: OPERATING SEGMENTS
  • TABLE 151.VEEVA: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.LIFE SCIENCE ANALYTICS SOFTWARE MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS IN LIFE SCIENCE ANALYTICS SOFTWARES MARKET, 2019
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
  • FIGURE 06.TOP PLAYER POSITIONING, 2019
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 09.LOW THREAT OF SUBSTITUTIONS
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 11.MODERATE COMPETITIVE RIVALRYS
  • FIGURE 12.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE: RESTRAINTS, DRIVERS AND OPPORTUNITY
  • FIGURE 13.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR DESCRIPTIVE ANALYTICS BY COUNTRY, 2019 & 2027(%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PREDICTIVE ANALYTICS BY COUNTRY, 2019 &2027 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PRESCRIPTIVEANALYTICS BY COUNTRY, 2019 &2027 (%)
  • FIGURE 16.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY CLINICAL TRIAL, 2019-2027 ($MILLION)
  • FIGURE 17.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY PRECLINICAL TRIALS, 2019-2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SALES AND MARKETING SUPPORT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SUPPLY CHAIN ANALYTICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR ON-PREMISE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR CLOUD, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 25.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 26.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 27.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RSEARCH CENTERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 28.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 29.ACCENTURE: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 30.ACCENTURE: REVENUE SHARE, BY SEGMENT, 2018 (%)
  • FIGURE 31.ACCENTURE: REVENUE SHARE, BY REGION, 2018(%)
  • FIGURE 32.CLARIVATE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 33.CLARIVATE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 34.CLARIVATE: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 35.COGNIZANT: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 36.COGNIZANT: REVENUE SHARE, BY SEGMENT, 2018 (%)
  • FIGURE 37.COGNIZANT: REVENUE SHARE, BY REGION, 2018 (%)
  • FIGURE 38.DASSAULT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 39.DASSAULT: REVENUE SHARE, BYREGION 2019 (%)
  • FIGURE 40.DELOITTE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 41.DELOITTE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 42.IQVIA: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 43.IQVIA: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 44.IQVIA: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 45.MICROSOFT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 46.MICROSOFT: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 47.MICROSOFT: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 48.ORACLE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.ORACLE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.ORACLE: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 51.VEEVA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 52.VEEVA: REVENUE SHARE, BY PRODUCT, 2020 (%)
  • FIGURE 53.VEEVA: REVENUE SHARE, BY REGION, 2020(%)
目次
Product Code: A06209

Title:
Life Science Analytics Software Market
by Product (Descriptive Analytics, Prescriptive Analytics, and Predictive Analytics), Application (Research & Development, Sales & Marketing Support, Regulatory Compliance, Supply Chain Analytics, and Pharmacovigilance), Delivery Model (On-Premise and Cloud), and End User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers and Third-Party Administrators): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global life science analytics software market size in 2019 was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. In addition, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.

The market is derived completely on the basis of the revenue generated through software license, subscription and maintenance. These are used in research & development, clinical trials, preclinical trials, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The major factors driving the growth of the life science analytics software is rise in in prevalence of chronic disease; and pressure to reduce healthcare expenditure and increased demand for improved patient outcomes. In addition, increase in adoption of analytics solutions in clinical trials and sales & marketing applications further boosts the market growth. However, lack of skilled professionals in developing countries and data privacy issues hamper the market growth. On the contrary, emergence of big data analytics to increase R&D productivity is anticipated to provide significant profitable opportunities for manufacturers in the life science analytics software industry.

The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current global life science analytics software market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment

The market forecast is studied from 2020 to 2027

The market size and estimations are based on a comprehensive analysis of key developments in the industry

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Product

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Application

  • Research and Development
  • Clinical Trials
  • Preclinical Trials
  • Sales and Marketing Support
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

By Delivery

  • On-Premise
  • Clouds

By End User

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third Party Administrators (TPAS)

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • KEY MARKET PLAYERS
  • Accenture Plc,
  • ArisGlobal LLC,
  • Chemical Abstracts Services (ACS)
  • Certara, L.P
  • Clarivate Analytics Plc.
  • Cognizant Technology Solutions Corporation
  • Dassault Systemes
  • Deloitte Touche Tohmatsu Limited.
  • IQVIA Holdings Inc
  • Microsoft Corporation
  • Oracle Corporation
  • TIBCO Software Inc.
  • Veeva Systems Inc.

The other players in the value chain include (profiles not included in the report):

  • IBM Corporation
  • Quintiles Inc
  • SAS Institute Inc.
  • SCIO Health Analytics
  • TAKE Solutions

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models
    • 1.4.4.Primary research

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
    • 3.2.3.Top player positioning, 2019
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Surge in prevalence of chronic disease
      • 3.4.1.2.Pressure to reduce healthcare expenditure & increased demand for improved patient outcomes.
      • 3.4.1.3.Rise in adoption of analytics solutions in clinical trials and sales & marketing applications
    • 3.4.2.Restraints
      • 3.4.2.1.Lack of skilled professionals in developing countries
      • 3.4.2.2.Data privacy issues
    • 3.4.3.Opportunity
      • 3.4.3.1.Emergence of big data analytics to increase R&D productivity

CHAPTER 4:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Descriptive analytics
    • 4.2.1.Key market trends, growth factors and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Predictive Analytics
    • 4.3.1.Key market trends, growth factors and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Prescriptive analytics
    • 4.4.1.Key market trends, growth factors and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Research and development
    • 5.2.1.Market size and forecast, by type
      • 5.2.1.1.Clinical Trials
      • 5.2.1.1.1.Market size and forecast
      • 5.2.1.2.Preclinical Trials
      • 5.2.1.2.1.Market size and forecast
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Sales and marketing support
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Regulatory compliance
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Supply chain analytics
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country
  • 5.6.Pharmacovigilance
    • 5.6.1.Market size and forecast, by region
    • 5.6.2.Market analysis, by country

CHAPTER 6:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.On-premise
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Cloud
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country

CHAPTER 7:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Pharmaceutical and biotechnology companies
    • 7.2.1.Market size and forecast, by region
    • 7.2.2.Market analysis, by country
  • 7.3.Medical device companies
    • 7.3.1.Market size and forecast, by region
    • 7.3.2.Market analysis, by country
  • 7.4.Research centers
    • 7.4.1.Market size and forecast, by region
    • 7.4.2.Market analysis, by country
  • 7.5.Third-party administrators
    • 7.5.1.Market size and forecast, by region
    • 7.5.2.Market analysis, by country

CHAPTER 8:LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends, growth factors and opportunities
    • 8.2.2.North America life science analytics software market, by country
      • 8.2.2.1.U.S. life science analytics software market, by product
      • 8.2.2.2.U.S life science analytics software market, by application
      • 8.2.2.3.U.S. life science analytics software market, by delivery model
      • 8.2.2.4.U.S. life science analytics software market, by end user
      • 8.2.2.5.Canada life science analytics software market, by product
      • 8.2.2.6.Canada life science analytics software market, by application
      • 8.2.2.7.Canada life science analytics software market, by delivery model
      • 8.2.2.8.Canada life science analytics software market, by end user
      • 8.2.2.9.Mexico life science analytics software market, by product
      • 8.2.2.10.Mexico life science analytics software market, by application
      • 8.2.2.11.Mexico life science analytics software market, by delivery model
      • 8.2.2.12.Mexico life science analytics software market, by end user
    • 8.2.3.North America life science analytics software market, by product
    • 8.2.4.North America life science analytics software market, by application
    • 8.2.5.North America life science analytics software market, by delivery model
    • 8.2.6.North America life science analytics software market, by end user
  • 8.3.Europe
    • 8.3.1.Key market trends, growth factors and opportunities
    • 8.3.2.Europe life science analytics software market, by country
      • 8.3.2.1.UK life science analytics software market, by product
      • 8.3.2.2.UK life science analytics software market, by application
      • 8.3.2.3.UK life science analytics software market, by delivery model
      • 8.3.2.4.UK life science analytics software market, by end user
      • 8.3.2.5.Germany life science analytics software market, by product
      • 8.3.2.6.Germany life science analytics software market, by application
      • 8.3.2.7.Germany life science analytics software market, by delivery model
      • 8.3.2.8.Germany life science analytics software market, by end user
      • 8.3.2.9.France life science analytics software market, by product
      • 8.3.2.10.France life science analytics software market, by application
      • 8.3.2.11.France life science analytics software market, by delivery model
      • 8.3.2.12.France life science analytics software market, by end user
      • 8.3.2.13.Italy life science analytics software market, by product
      • 8.3.2.14.Italy life science analytics software market, by application
      • 8.3.2.15.Italy life science analytics software market, by delivery model
      • 8.3.2.16.Italy life science analytics software market, by end user
      • 8.3.2.17.Spain life science analytics software market, by product
      • 8.3.2.18.Spain life science analytics software market, by application
      • 8.3.2.19.Spain life science analytics software market, by delivery model
      • 8.3.2.20.Spain life science analytics software market, by end user
      • 8.3.2.21.Rest of Europe life science analytics software market, by product
      • 8.3.2.22.Rest of Europe life science analytics software market, by application
      • 8.3.2.23.Rest of Europe life science analytics software market, by delivery model
      • 8.3.2.24.Rest of Europe life science analytics software market, by end user
    • 8.3.3.Europe life science analytics software market, by product
    • 8.3.4.Europe life science analytics software market, by application
    • 8.3.5.Europe life science analytics software market, by delivery model
    • 8.3.6.Europe life science analytics software market, by end user
  • 8.4.Asia-pacific
    • 8.4.1.Key market trends, growth factors and opportunities
    • 8.4.2.Asia-Pacific life science analytics software market, by country
      • 8.4.2.1.Japan life science analytics software market, by product
      • 8.4.2.2.Japan life science analytics software market, by application
      • 8.4.2.3.Japan life science analytics software market, by delivery model
      • 8.4.2.4.Japan life science analytics software market, by end user
      • 8.4.2.5.China life science analytics software market, by product
      • 8.4.2.6.China life science analytics software market, by application
      • 8.4.2.7.China life science analytics software market, by delivery model
      • 8.4.2.8.China life science analytics software market, by end user
      • 8.4.2.9.Australia life science analytics software market, by product
      • 8.4.2.10.Australia life science analytics software market, by application
      • 8.4.2.11.Australia life science analytics software market, by delivery model.
      • 8.4.2.12.Australia life science analytics software market, by end user
      • 8.4.2.13.India life science analytics software market, by product
      • 8.4.2.14.India life science analytics software market, by application
      • 8.4.2.15.India life science analytics software market, by delivery model
      • 8.4.2.16.India life science analytics software market, by end user
      • 8.4.2.17.Rest of Asia-Pacific life science analytics software market, by product
      • 8.4.2.18.Rest of Asia-Pacific life science analytics software market, by application
      • 8.4.2.19.Rest of Asia-Pacific life science analytics software market, by delivery model
      • 8.4.2.20.Rest of Asia-Pacific life science analytics software market, by end user
    • 8.4.3.Asia-Pacific life science analytics software market, by product
    • 8.4.4.Asia-Pacific life science analytics software market, by application
    • 8.4.5.Asia-Pacific life science analytics software market, by delivery model
    • 8.4.6.Asia-Pacific life science analytics software market, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends, growth factors and opportunities
    • 8.5.2.LAMEA life science analytics software market, by country
      • 8.5.2.1.Brazil life science analytics software market, by product
      • 8.5.2.2.Brazil life science analytics software market, by application
      • 8.5.2.3.Brazil life science analytics software market, by delivery model
      • 8.5.2.4.Brazil life science analytics software market, by end user
      • 8.5.2.5.Saudi Arabia life science analytics software market, by product
      • 8.5.2.6.Saudi Arabia life science analytics software market, by application
      • 8.5.2.7.Saudi Arabia life science analytics software market, by delivery model
      • 8.5.2.8.Saudi Arabia life science analytics software market, by end user
      • 8.5.2.9.South Africa life science analytics software market, by product
      • 8.5.2.10.South Africa life science analytics software market, by application
      • 8.5.2.11.South Africa life science analytics software market, by delivery model
      • 8.5.2.12.South Africa life science analytics software market, by end user
      • 8.5.2.13.Rest of LAMEA life science analytics software market, by product
      • 8.5.2.14.Rest of LAMEA life science analytics software market, by application
      • 8.5.2.15.Rest of LAMEA life science analytics software market, by delivery model
      • 8.5.2.16.Rest of LAMEA life science analytics software market, by end user
    • 8.5.3.LAMEA life science analytics software market, by product
    • 8.5.4.LAMEA life science analytics software market, by application
    • 8.5.5.LAMEA life science analytics software market, by delivery model
    • 8.5.6.LAMEA life science analytics software market, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.ACCENTURE PLC
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
  • 9.2.ARISGLOBAL LLC
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Key strategic moves and developments
  • 9.3.CHEMICAL ABSTRACTS SERVICES (ACS)
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
  • 9.4.CERTARA, L.P.
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Key strategic moves and developments
  • 9.5.CLARIVATE ANALYTICS PLC
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance
    • 9.5.6.Key strategic moves and developments
  • 9.6.COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.DASSAULT SYSTEMES
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments:
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
  • 9.8.DELOITTE
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
  • 9.9.IQVIA HOLDINGS INC
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
    • 9.9.5.Business performance
    • 9.9.6.Key strategic moves and developments
  • 9.10.MICROSOFT CORPORATION
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance
  • 9.11.ORACLE CORPORATION
    • 9.11.1.Company overview
    • 9.11.2.Company snapshot
    • 9.11.3.Operating business segments
    • 9.11.4.Product portfolio
    • 9.11.5.Business performance
    • 9.11.6.Key strategic moves and developments
  • 9.12.TIBCO SOFTWARE INC
    • 9.12.1.Company overview
    • 9.12.2.Operating business segments
    • 9.12.3.Product portfolio
  • 9.13.VEEVA SYSTEMS INC
    • 9.13.1.Company overview
    • 9.13.2.Company snapshot
    • 9.13.3.Operating business segments
    • 9.13.4.Product portfolio
    • 9.13.5.Business performance
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.